This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PANCREAS_NEUROENDOCRINE_EXALLC for full statistics.
Neuroendocrine tumor and carcinoma of pancreas
C3_PANCREAS_NEUROENDOCRINE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
C25
Cancer registry: Morphology ICD-O-3
8240|8246|8249
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
138
Check minimum number of events None
138
Include endpoints None
138
Remove individuals based on genotype QC
129
C3_PANCREAS_NEUROENDOCRINE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of pancreas
based on the number of shared cases.
Broader endpoints:
- Neuroendocrine tumor and carcinoma of pancreas (controls excluding all cancers)
- Malignant neoplasm of pancreas (controls excluding all cancers)
- Malignant neoplasm of pancreas
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 129 | 56 | 73 |
| Unadjusted prevalence (%) | 0.03 | 0.02 | 0.04 |
| Mean age at first event (years) | 59.54 | 56.35 | 62.00 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_PANCREAS_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of pancreas
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Neuroendocrine tumor and carcinoma of pancreas
↥Endpoint not on priority list, no data to show.